ATE226436T1 - Neue verwendung von dexmedetomidin - Google Patents

Neue verwendung von dexmedetomidin

Info

Publication number
ATE226436T1
ATE226436T1 AT94924894T AT94924894T ATE226436T1 AT E226436 T1 ATE226436 T1 AT E226436T1 AT 94924894 T AT94924894 T AT 94924894T AT 94924894 T AT94924894 T AT 94924894T AT E226436 T1 ATE226436 T1 AT E226436T1
Authority
AT
Austria
Prior art keywords
pct
dexmedetomidine
sec
date
new use
Prior art date
Application number
AT94924894T
Other languages
English (en)
Inventor
Pia Helena Jaatinen
Antti Lauri Juhani Hervonen
Esa Henrik Heinonen
Lauri Sakari Nieminen
Original Assignee
Orion Yhtymae Oy
Pia Helena Jaatinen
Antti Lauri Juhani Hervonen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy, Pia Helena Jaatinen, Antti Lauri Juhani Hervonen filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE226436T1 publication Critical patent/ATE226436T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT94924894T 1993-08-25 1994-08-24 Neue verwendung von dexmedetomidin ATE226436T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9317636A GB2281206A (en) 1993-08-25 1993-08-25 Use of dexmedetomidine
PCT/FI1994/000371 WO1995005820A1 (en) 1993-08-25 1994-08-24 Novel use of dexmedetomidine

Publications (1)

Publication Number Publication Date
ATE226436T1 true ATE226436T1 (de) 2002-11-15

Family

ID=10740984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94924894T ATE226436T1 (de) 1993-08-25 1994-08-24 Neue verwendung von dexmedetomidin

Country Status (8)

Country Link
US (1) US5712301A (de)
EP (1) EP0719141B1 (de)
AT (1) ATE226436T1 (de)
AU (1) AU7500794A (de)
DE (1) DE69431601T2 (de)
ES (1) ES2185660T3 (de)
GB (1) GB2281206A (de)
WO (1) WO1995005820A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514327A (en) * 1993-12-14 1996-05-07 Lsi Logic Corporation Powder metal heat sink for integrated circuit devices
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
AU778522B2 (en) 1999-10-29 2004-12-09 Orion Corporation Treatment or prevention of hypotension and shock
DK2320911T3 (da) 2008-08-01 2014-11-03 Eye Therapies Llc Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf
US20100203165A1 (en) * 2008-08-01 2010-08-12 Gerald Horn Compositions and methods for treatment of disorders or conditions of the eye
US12246013B2 (en) 2008-08-01 2025-03-11 Eye Therapies Llc Vasoconstriction compositions and methods of use
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US8987270B2 (en) 2009-07-27 2015-03-24 Eye Therapies Llc Formulations of selective alpha-2 agonists and methods of use thereof
WO2011075621A1 (en) * 2009-12-17 2011-06-23 Alpha Synergy Development, Inc. Compositions and methods for ophthalmic delivery of nasal decongestants
US8445526B2 (en) 2011-02-03 2013-05-21 Glaucoma & Nasal Therapies Llc Compositions and methods for treatment of glaucoma
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
SG10201604653TA (en) 2011-12-11 2016-07-28 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
US8999938B2 (en) 2013-06-21 2015-04-07 Gnt Llc Ophthalmic lipophilic drug delivery vehicle formulations
TWI645866B (zh) 2013-10-07 2019-01-01 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
US20150098997A1 (en) 2013-10-07 2015-04-09 Teikoku Pharma Usa, Inc. Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
JP6188933B2 (ja) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
RU2723761C1 (ru) 2016-10-31 2020-06-17 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы устранения боли с использованием устройств для трансдермальной доставки дексмедетомидина
CN110337290A (zh) 2016-12-31 2019-10-15 比奥克斯塞尔医疗股份有限公司 舌下右旋美托咪啶用于治疗激越的用途
EP4523752A3 (de) 2018-06-27 2025-05-14 BioXcel Therapeutics, Inc. Filmformulierungen mit dexmedetomidin und verfahren zur herstellung davon
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care

Also Published As

Publication number Publication date
ES2185660T3 (es) 2003-05-01
EP0719141B1 (de) 2002-10-23
WO1995005820A1 (en) 1995-03-02
US5712301A (en) 1998-01-27
GB2281206A (en) 1995-03-01
AU7500794A (en) 1995-03-21
DE69431601T2 (de) 2003-07-03
GB9317636D0 (en) 1993-10-13
EP0719141A1 (de) 1996-07-03
DE69431601D1 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE226436T1 (de) Neue verwendung von dexmedetomidin
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
ATE300287T1 (de) Behandlung von normaldruckglaukom mit valsartan
NO953371L (no) Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS
DE59308848D1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
WO1999048489A3 (en) Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
DE69636393D1 (de) Montirelin zur verhinderung der schlafapnoe
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
SE9404438D0 (sv) New process
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
NO940093L (no) Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
PL322847A1 (en) Condensed b-carbolins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties